VA Portland Healthcare System named one of 18 VA sites to test efficacy of GLP-1 as treatment for alcohol use disorder
PORTLAND, Oregon — VA Portland Healthcare System today announced its participation in a new clinical trial to evaluate the efficacy of semaglutide, a GLP-1 receptor agonist used to treat diabetes, as treatment for alcohol use disorder (AUD). Currently, […]
